ACA:EURONEXT PARIS
Credit Agricole SA
Data as of 2026-03-11 - not real-time
$108.24
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Arcosa, Inc. is trading at $108.24, well below its 20‑day SMA of $119.44 and 50‑day SMA of $115.91, indicating short‑term weakness despite a bullish trend direction. The RSI of 37 signals oversold conditions, while a bearish MACD histogram (-1.82) suggests momentum may still be negative. Volatility is high at 55.7% over 30 days and beta exceeds 1 (1.12), reflecting sensitivity to market moves. Valuation metrics show a trailing PE of 25.5 versus an industry average of 29.4, yet the DCF fair value of $2.14 per share implies the stock is significantly overvalued, with an upside/downside estimate of only +18% relative to current price. Analysts rate the stock as a strong buy with a mean target of $127.8, and the dividend yield is modest at 0.18% with an ultra‑low payout ratio of 4.7%, supporting dividend sustainability. Recent Q4 earnings reported a 7.6% revenue increase to $716.7 million and EPS growth to $1.15, beating the prior year, while the announced $450 million divestiture of the barge business enhances balance‑sheet flexibility. These fundamentals, combined with increasing volume trends, suggest the stock may rebound toward its $131 resistance level, but the current price remains near the $101.6 support.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price below short‑term SMAs indicating near‑term support testing
- Bearish MACD despite oversold RSI
- Increasing volume suggesting potential accumulation
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong earnings beat and 7.6% revenue growth
- Analyst consensus strong‑buy with ~18% upside
- Dividend sustainability and low payout ratio
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Strategic divestiture of barge business improving financial flexibility
- Stable cash flow generation and moderate leverage
- Sector tailwinds in infrastructure and construction markets
Key Metrics & Analysis
Financial Health
Revenue Growth7.60%
Profit Margin7.23%
P/E Ratio25.5
ROE8.22%
ROA3.92%
Debt/Equity59.91
P/B Ratio2.0
Op. Cash Flow$341.1M
Free Cash Flow$76.6M
Industry P/E29.4
Technical Analysis
TrendBullish
RSI37.1
Support$101.61
Resistance$131.00
MA 20$119.44
MA 50$115.91
MA 200$100.20
MACDBearish
VolumeIncreasing
Fear & Greed Index76.91
Valuation
Fair Value$2.14
Target Price$127.83
Upside/Downside18.10%
GradeOvervalued
TypeBlend
Dividend Yield0.18%
Risk Assessment
Beta1.12
Volatility55.68%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow
More Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.